It's a good thing the genomics community has been so involved in studies of tuberculosis and Yersinia pestis. Recent news reports indicate that while overall rates of TB are hitting a plateau, a drug-resistant strain of the disease is emerging.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.